Bye-law 20, National Medical Commission (Licensing of The import of drugs) Bye-laws, 2022 [SD7-07F]

As at 7 September 2026. In force from 15 October 2022.

In National Medical Commission (Licensing of The import of drugs) Bye-laws, 2022 [R1M-SGR]. This text from 15 October 2022. No other text held.

Synthetic. This instrument, its title, its number and the words of this section are generated by the register.

Cite: Bye-law 20, National Medical Commission (Licensing of The import of drugs) Bye-laws, 2022 [SD7-07F]. Machine: SD7-07F.

Name board.—Every importer of drugs shall exhibit, at the entrance of every premises where the import of drugs is carried on, a board in the local language showing his name, the number and date of his certificate of registration and the hours during which the premises are open, shall correct the board within fifteen days of any change in those particulars, and shall report the correction to the Drugs Controller in Form 28 within sixty days of making it.

Defined terms in this text (0)

none

Made under this bye-law, or naming it (0)

none

Cited by (0)

none

Not held (0)

none

Duties published under this bye-law (0)

none